144 related articles for article (PubMed ID: 19775446)
1. The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity.
Zhang Y; Liu Y; Yang YX; Xia JH; Zhang HX; Li HB; Yu CZ
J Exp Clin Cancer Res; 2009 Sep; 28(1):130. PubMed ID: 19775446
[TBL] [Abstract][Full Text] [Related]
2. Polo-like kinase (PLK) expression in endometrial carcinoma.
Takai N; Miyazaki T; Fujisawa K; Nasu K; Hamanaka R; Miyakawa I
Cancer Lett; 2001 Aug; 169(1):41-9. PubMed ID: 11410324
[TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase: a novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer.
Wolf G; Hildenbrand R; Schwar C; Grobholz R; Kaufmann M; Stutte HJ; Strebhardt K; Bleyl U
Pathol Res Pract; 2000; 196(11):753-9. PubMed ID: 11186170
[TBL] [Abstract][Full Text] [Related]
4. A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro.
Kawata E; Ashihara E; Nakagawa Y; Kiuchi T; Ogura M; Yao H; Sakai K; Tanaka R; Nagao R; Yokota A; Takeuchi M; Kimura S; Hirai H; Maekawa T
Cancer Lett; 2010 Aug; 294(2):245-53. PubMed ID: 20206440
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.
Wang ZX; Xue D; Liu ZL; Lu BB; Bian HB; Pan X; Yin YM
Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase.
Jang YJ; Ma S; Terada Y; Erikson RL
J Biol Chem; 2002 Nov; 277(46):44115-20. PubMed ID: 12207013
[TBL] [Abstract][Full Text] [Related]
7. [Influence of survivin gene repression by RNA interference on the radiosensitivity and chemosensitivity to cisplatin of cervical cancer cell HeLa].
Song H; Xin XY; Xiao F; Wang DT; Han X; Guo HL
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):554-8. PubMed ID: 17083843
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase-1 immunoreactivity is associated with metastases in cutaneous melanoma.
Kaczorowski M; Borowiec T; Donizy P; Pagacz K; Fendler W; Lipinski A; Halon A; Matkowski R
J Cutan Pathol; 2017 Oct; 44(10):819-826. PubMed ID: 28626898
[TBL] [Abstract][Full Text] [Related]
9. [PLK1 Expression in Mantle Cell Lymphoma and Its Clinical Significance].
Shen LY; Lin CM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):833-838. PubMed ID: 31204940
[TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase 1 is a potential therapeutic target in human melanoma.
Jalili A; Moser A; Pashenkov M; Wagner C; Pathria G; Borgdorff V; Gschaider M; Stingl G; Ramaswamy S; Wagner SN
J Invest Dermatol; 2011 Sep; 131(9):1886-95. PubMed ID: 21654832
[TBL] [Abstract][Full Text] [Related]
11. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
Bu Y; Yang Z; Li Q; Song F
Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of Aurora A positive multipolar mitoses in distinct molecular classes of colorectal carcinomas and effect of Aurora A inhibition.
Herz C; Schlürmann F; Batarello D; Fichter CD; Schöpflin A; Münch C; Hauschke D; Werner M; Lassmann S
Mol Carcinog; 2012 Sep; 51(9):696-710. PubMed ID: 21739483
[TBL] [Abstract][Full Text] [Related]
13. PLK-1 Silencing in Bladder Cancer by siRNA Delivered With Exosomes.
Greco KA; Franzen CA; Foreman KE; Flanigan RC; Kuo PC; Gupta GN
Urology; 2016 May; 91():241.e1-7. PubMed ID: 26876462
[TBL] [Abstract][Full Text] [Related]
14. siRNA targeting PLK-1 induces apoptosis of synoviocytes in rheumatoid arthritis.
Wada M; Kawahito Y; Kimura S; Kohno M; Ishino H; Kimura M; Omoto A; Yamamoto A; Hamaguchi M; Tsubouchi Y; Tokunaga D; Hojo T; Ashihara E; Maekawa T; Yoshikawa T
Biochem Biophys Res Commun; 2007 Jun; 357(2):353-9. PubMed ID: 17434144
[TBL] [Abstract][Full Text] [Related]
15. Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of Survivin expression.
He Z; Wu J; Dang H; Lin H; Zheng H; Zhong D
Cancer Lett; 2011 Apr; 303(2):92-8. PubMed ID: 21330050
[TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase and survivin are esophageal tumor-specific promoters.
Sato F; Abraham JM; Yin J; Kan T; Ito T; Mori Y; Hamilton JP; Jin Z; Cheng Y; Paun B; Berki AT; Wang S; Shimada Y; Meltzer SJ
Biochem Biophys Res Commun; 2006 Apr; 342(2):465-71. PubMed ID: 16487489
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma.
Feng YB; Lin DC; Shi ZZ; Wang XC; Shen XM; Zhang Y; Du XL; Luo ML; Xu X; Han YL; Cai Y; Zhang ZQ; Zhan QM; Wang MR
Int J Cancer; 2009 Feb; 124(3):578-88. PubMed ID: 19004025
[TBL] [Abstract][Full Text] [Related]
18. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
Reagan-Shaw S; Ahmad N
FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
[TBL] [Abstract][Full Text] [Related]
19. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
Zhou Q; Bai M; Su Y
Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023
[TBL] [Abstract][Full Text] [Related]
20. [Expression of plk-1 gene in acute leukemia patients and its significance].
Mao HW; Liu WL; Zhou JF; Sun HY; Xu HZ; Luo XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):876-9. PubMed ID: 17096880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
